The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
										The DL-Tartaric acid Drug Master File in Japan (DL-Tartaric acid JDMF) empowers DL-Tartaric acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
										PMDA reviews the DL-Tartaric acid JDMF during the approval evaluation for pharmaceutical products. At the time of DL-Tartaric acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
										click here to find a list of DL-Tartaric acid suppliers with JDMF on PharmaCompass.